Interest in medical cannabis and cannabis-based medicinal products (CBMPs) has
increased greatly in recent years. Two cannabinoids are of principal importance; delta-9 …

Cannabis sativa L. is a monotypic genus belonging to the family Cannabaceae. It is one of
the oldest species cultivated by humans, believed to have originated in Central Asia. In …

Background: Despite increasing medical cannabis use, research has yet to establish
whether and to what extent products containing delta-9-tetrahydrocannabinol (THC) impact …

Methods In this semi-naturalistic, open-label trial, patients with various health conditions
attended a single laboratory session in which they self-administered a standard dose of …

Background Many patients with cancer use cannabis to help alleviate untreated cancer
symptoms and side effects. Methods We examined associations of perceived benefits and …

Introduction While there is increasing evidence of the effects of cannabis‐based medicinal
products (CBMPs) on health‐related quality of life (HRQoL), a major limitation of the current …

Chronic pain is primarily conceptualized as a disease in its own right when it is associated
with emotional distress and functional impairment. Pathophysiologically, dysfunction of the …

Introduction Cannabis is increasingly available to individuals in the United States, with the
majority of states legalizing medical or recreational cannabis use. Cannabis expectancies …

There is a significant global upsurge in the number and proportion of older persons in the
population. With this comes an increasing prevalence of age-related conditions which pose …

Background Cannabis was legalised for medical purposes in 2016. Uptake was initially
slow, but since 2019 there has been a large increase in the number of Australians who have …